Vancouver, Canada: CDRD – The Centre for Drug Research and Development, Canada’s national drug development and commercialization centre, is pleased to announce the appointment of Sacha Mann as an Entrepreneur-in-Residence.
Sacha Mann has a unique breadth of experience in life sciences companies. Sacha has been a life sciences investor, company innovator, and leader, and she has managed the entire commercialization cycle from spinning technology out of academia, raising venture capital financing, in-licensing assets into emerging companies, and partnering with global players. She has worked and invested across Canada and globally, most recently as CEO and Director of Biosys UK Ltd., a venture-backed, clinical stage microbiome company headquartered in London.
As an Entrepreneur-in-Residence, Sacha will work with CDRD leadership to identify specific areas of strategic commercial opportunity, and then in partnership with other stakeholders, drive the building of a new company of scale that can develop those opportunities, and grow into a strong new anchor for Canada’s life science sector.
Gordon C. McCauley, President and CEO of CDRD commented, “Sacha has a rare combination of skills in both investment and operations. She has formed new companies and raised venture capital into companies she has run; and has invested in early-stage companies around the world. She represents exactly the kind of talent Canada needs to be a global innovation leader. We are extremely pleased that Sacha is bringing that talent to CDRD, and to the creation of strong new Canadian life sciences companies of scale.”
Sacha Mann was also previously an investor with Inventages Venture Capital, a respected global venture capital firm focused on life sciences, nutrition and wellness that raised €500M for their most recent fund. Prior to Inventages, she was an early-stage investor focused on innovation, company formation and investment in the UK (Archangels) and Canada (BDC Capital).
Sacha Mann holds a BSc in Chemistry (with Honours) from the University of British Columbia; an MSc from Johns Hopkins University (First Class Standing) in Biotechnology; and an MBA specializing in Technology (First Class Standing) from Simon Fraser University. She is a member of the Kauffman Fellows (Class 12), a global venture leadership organization with over 500 Fellows in over 40 countries.
For additional information, please contact:
Senior Director, Communications and External Affairs
CDRD – The Centre for Drug Research and Development